Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 12

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 12
---
. EXPAREL Patient Council In 2025, we introduced the EXPAREL Patient Council and Ambassador Program. This initiative aims to raise awareness for EXPAREL, encourage patients to discuss their postsurgical pain management options and experience with EXPAREL and place patients (and their insights and stories) at the center of our go-to-market strategy. Our Patient Council Members are the heart of our initiative, driving our mission forward. These passionate individuals, who have experienced the positive impacts of EXPAREL, are dedicated to sharing their stories to spread awareness of the benefits of recovery with EXPAREL. They will ensure that patient voices and experiences remain core to our efforts. In addition to our Patient Council Members, our program includes Ambassadors who are individuals that have experienced EXPAREL or are considering surgery. Our Ambassadors will provide valuable feedback, share insights about their own patient experience, and share their stories, helping us connect with a wider audience and deepen our understanding of patient needs. Through the EXPAREL Patient Council and Ambassador Program, we aim to empower patients, foster a community of informed decision-makers, and drive meaningful change in pain management. Spotlighting the Surgical Gateway We were the first company to highlight the connection between surgery and opioid overprescription. We launched several national campaigns designed to raise public awareness about the risks of opioids and highlight the availability of and expanded access to non-opioid options for postsurgical pain. This included producing Gateway , an award-winning documentary that reveals how postsurgical opioid use can inadvertently lead to addiction, emphasizing the need for safer alternatives. OPIOID REDUCTION MISSION Overreliance on opioids in the postsurgical setting has caused a rapid deluge of opioid misuse, abuse, and addiction. Opioid addiction in the U.S. has reached epidemic proportions, with the U.S. Centers for Disease Control and Prevention (CDC) reporting that over 87,000 Americans died from a drug overdose in the 12-month period ending September 2024. While this is a 24% decline from the previous 12-month period, overdose remains the leading cause of death among Americans aged 18-44. A recent meta- analysis of 33 studies and nearly two million patients who underwent various procedures showed that across a variety of surgical procedures, 7% of patients continued to fill opioid prescriptions more than three months after surgery. The highest rates were observed in orthopedic procedures. Studies have also shown that misuse of prescription opioids is a primary predictor of heroin usage and that 4% to 6